Call +1 858 457-8383 Fax +1 858 457-8484

Concanamycin A (high purity)

BVT-0237-C025 25 µg $80.00
BVT-0237-C100 100 µg $160.00
BVT-0237-M001 1 mg $720.00
Actions
Select size:

* Required Fields

Amount:
Add to Cart
Call +1 858 457-8383
Fax +1 858 457-8484
Contact Us!

Additional Information

Product Data
Synonyms Folimycin; Antibiotic TAN 1323B; Antibiotic X4357B
Properties
Formula C46H75NO14
MW 866.1
CAS 80890-47-7
RTECS CB9732000
Source/Host Chemicals Isolated from Streptomyces sp.
Purity ≥98% (HPLC)
Appearance White to off-white solid.
Solubility Soluble in methanol, DMSO or acetonitrile; insoluble in water.
Identity Determined by 1H-NMR.
Origin Manufactured by BioViotica.
InChi Key DJZCTUVALDDONK-MSPZYORZSA-N
Product Type Chemical
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light when in solution.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C. After reconstitution protect from light at -20°C.
Documents
MSDS Download Document Download

Product Description

  • Antibiotic.
  • More potent and specific H+-ATPase inhibitor than bafilomycin A1 (Prod. No. BVT-0252).
  • Inhibits acidification of organelles such as lysosomes and the Golgi apparatus.
  • Blocks cell surface expression of viral glycoproteins without affecting their synthesis.
  • Cytotoxic in a number of cell lines in a cell viability assay.
  • Induces nitric oxide (NO) production.
  • Autophagy inhibitor.

Product References

  1. Isolation and characterization of concanamycins A, B and C: H. Kinashi, et al.; J. Antibiot. 37, 1333 (1984)
  2. Folimycin (concanamycin A), a specific inhibitor of V-ATPase, blocks intracellular translocation of the glycoprotein of vesicular stomatitis virus before arrival to the Golgi apparatus: M. Muroi, et al.; Cell Struct. Funct. 18, 139 (1993)
  3. Folimycin (concanamycin A), an inhibitor of V-type H(+)-ATPase, blocks cell-surface expression of virus-envelope glycoproteins: M. Muroi, et al.; BBRC 193, 999 (1993)
  4. Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases: S. Drose, et al.; Biochemistry 32, 3902 (1993)
  5. Involvement of the vacuolar H(+)-ATPases in the secretory pathway of HepG2 cells: M. Yilla, et al.; J. Biol. Chem. 268, 19092 (1993)
  6. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells: F.J. Sharom, et al.; Biochem. J. 308 (Pt2), 381 (1995)
  7. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death: T. Nishihara, et al.; BBRC 212, 255 (1995)
  8. Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c: M. Huss, et al.; J. Biol. Chem. 277, 40544 (2002)
  9. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells: J. Hong, et al.; J. Pharmacol. Exp. Ther. 319, 672 (2006)
  10. Degradation of oxidized proteins by autophagy during oxidative stress in Arabidopsis: Y. Xiong, et al.; Plant Physiol. 143, 291 (2007)
  11. Inhibitors of the V0 subunit of the vacuolar H+-ATPase prevent segregation of lysosomal- and secretory-pathway proteins: J.A. Sobota, et al.; J. Cell Sci. 122, 3542 (2009)
  12. Inhibitors of V-ATPase: old and new players: M. Huss, et al.; J. Exp. Biol. 212, 341 (2009)
No reviews for this product yet.